🇫🇷
France · FR · FR:60535331
ESTRING 2 mg, système de diffusion vaginal
ATC G03CA03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerPFIZER HOLDING FRANCE
CountryFR (France)
ATC codeG03CA03
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009275661891 sachet(s) polytéréphtalate (PET) aluminium polyéthylène basse densité (PEBD) de 1 dispositif(s)
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "60535331",
"date_amm": "2014-01-27",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "système de diffusion",
"voies_administration": "vaginale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code G03CA03.
- GBAdgyn Estro 2mg tabletsKyowa Kirin Ltd
- GBAerodiol 150micrograms/dose nasal sprayServier Laboratories Ltd
- GBBedol 2mg tabletsReSource Medical UK Ltd
- NLCetura 0,5 mg tablettenACE Pharmaceuticals B.V.
- FIClimaraBayer Oy
- FIClimaraBayer Schering Pharma Oy
- 🇺🇸ClimaraBayer HealthCare Pharmaceuticals Inc.
- 🇺🇸ClimaraBayer HealthCare Pharmaceuticals Inc.
Access this data programmatically
Query ESTRING 2 mg, système de diffusion vaginal and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.